Clinical Trial Update: Drug Use Surveillance of Takecab for "Supplement to Helicobacter Pylori Eradication"

View source ↗

Summary

Clinical trial update documenting completion and posted results for a drug use surveillance study related to Takecab as a supplement to Helicobacter pylori erad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Duodenal Ulcer
• Gastric Malt Lymphoma
• Helicobacter Pylori Gastritis
• Idiopathic Thrombocytopenic Purpura

Drugs mentioned

• Takecab (tegoprazan)

Snippet

Sponsor: Takeda | Conditions: Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other | Status: COMPLETED | Results posted: 2019-03-22